NeoChord appointed Dr. Martin Leon as executive chair of the company’s U.S. early feasibility study of its Transcatheter Nexus system.
Leon will be responsible for overseeing and leading the company’s initiatives to advance its U.S. regulatory strategy for the Nexus system. He will also guide the company’s overall global regulatory strategy as it continues to enroll patients in its European early feasibility study (EFS).
Get the full story on our sister site, Medical Tubing + Extrusion.